$ZOM
Zomedica Corp. Stock $zom

$zom Overview Financials Valuation SEC Filings Company Website

2020 Form 10-K Financial Statement

#000117184321001378 Filed on February 26, 2021

Income Statement

Concept	2020	2019 Q4	2019
Revenue	$0.00	$0.00	$0.00
YoY Change
Cost Of Revenue	$0.00
YoY Change
Gross Profit	$0.00
YoY Change
Gross Profit Margin
Selling, General & Admin	$8.721M	$1.864M	$8.651M
YoY Change	0.81%	2.89%	42.85%
% of Gross Profit
Research & Development	$8.044M	$790.0K	$10.35M
YoY Change	-22.25%	-87.94%	0.27%
% of Gross Profit
Depreciation & Amortization	$305.9K	$203.7K	$277.2K
YoY Change	10.38%	279.81%	36.07%
% of Gross Profit
Operating Expenses	$16.76M	$2.857M	$10.35M
YoY Change	62.05%	-66.05%	0.27%
Operating Profit	-$16.76M		-$19.78M
YoY Change	-15.26%		19.33%
Interest Expense	$732.00	$210.00	$18.34K
YoY Change	-96.01%	-104.18%
% of Operating Profit
Other Income/Expense, Net	$8.600K
YoY Change
Pretax Income	-$16.91M	-$2.857M	-$19.78M
YoY Change	-14.52%	-66.08%	18.84%
Income Tax	$0.00	$0.00
% Of Pretax Income
Net Earnings	-$16.91M	-$2.857M	-$19.78M
YoY Change	-14.52%	-66.08%	18.84%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share	-$46.40K	-$26.44K	-$186.1K
COMMON SHARES
Basic Shares Outstanding	364.4M		106.3M
Diluted Shares Outstanding	364.4M shares		106.3M

Balance Sheet

Concept	2020	2019 Q4	2019
SHORT-TERM ASSETS
Cash & Short-Term Investments	$61.99M	$510.6K	$510.6K
YoY Change	12041.19%	-73.68%	-73.68%
Cash & Equivalents	$61.99M	$510.6K	$510.6K
Short-Term Investments
Other Short-Term Assets	$727.8K	$1.229M	$1.229M
YoY Change	-40.76%	-34.2%	-34.2%
Inventory
Prepaid Expenses
Receivables	$146.2K	$67.62K	$67.62K
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$62.87M	$1.807M	$1.807M
YoY Change	3379.41%	-53.2%	-53.2%
LONG-TERM ASSETS
Property, Plant & Equipment	$1.902M	$729.1K	$1.833M
YoY Change	3.76%	1.68%	155.59%
Goodwill
YoY Change
Intangibles		$543.4K
YoY Change		4061.4%
Long-Term Investments
YoY Change
Other Assets	$1.000M	$0.00	$0.00
YoY Change		-100.0%	-100.0%
Total Long-Term Assets	$3.278M	$2.376M	$2.376M
YoY Change	37.96%	9.37%	9.37%
TOTAL ASSETS
Total Short-Term Assets	$62.87M	$1.807M	$1.807M
Total Long-Term Assets	$3.278M	$2.376M	$2.376M
Total Assets	$66.14M	$4.183M	$4.183M
YoY Change	1481.27%	-30.67%	-30.67%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.249M	$2.088M	$2.088M
YoY Change	-40.19%	-12.16%	-12.16%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt	$527.4K	$0.00	$0.00
YoY Change
Long-Term Debt Due	$252.8K
YoY Change
Total Short-Term Liabilities	$2.029M	$2.088M	$2.088M
YoY Change	-2.81%	-12.16%	-12.16%
LONG-TERM LIABILITIES
Long-Term Debt	$1.088M		$0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities	$1.088M		$0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities	$2.029M	$2.088M	$2.088M
Total Long-Term Liabilities	$1.088M		$0.00
Total Liabilities	$3.117M	$2.088M	$2.088M
YoY Change	49.3%	-12.16%	-12.16%
SHAREHOLDERS EQUITY
Retained Earnings		-$52.06M
YoY Change		61.3%
Common Stock		$42.19M
YoY Change		33.3%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$63.03M	$2.095M	$2.095M
YoY Change
Total Liabilities & Shareholders Equity	$66.14M	$4.183M	$4.183M
YoY Change	1481.27%	-30.67%	-30.67%

Cashflow Statement

Concept	2020	2019 Q4	2019
OPERATING ACTIVITIES
Net Income	-$16.91M	-$2.857M	-$19.78M
YoY Change	-14.52%	-66.08%	18.84%
Depreciation, Depletion And Amortization	$305.9K	$203.7K	$277.2K
YoY Change	10.38%	279.81%	36.07%
Cash From Operating Activities	-$16.24M	-$1.866M	-$15.63M
YoY Change	3.87%	-43.93%	40.25%
INVESTING ACTIVITIES
Capital Expenditures	$14.85K	-$29.93K	$155.5K
YoY Change	-90.45%	32.26%	-75.24%
Acquisitions
YoY Change
Other Investing Activities	$1.023M	$0.00	$0.00
YoY Change			-100.0%
Cash From Investing Activities	$1.006M	-$29.93K	-$686.9K
YoY Change	-246.41%	119.59%	10.98%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net	$56.50M		$3.000M
YoY Change	1783.21%		-63.78%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	$76.71M	-81.00K	14.89M
YoY Change	415.16%	-101.7%	45.16%
NET CHANGE
Cash From Operating Activities	-$16.24M	-1.866M	-15.63M
Cash From Investing Activities	$1.006M	-29.93K	-686.9K
Cash From Financing Activities	$76.71M	-81.00K	14.89M
Net Change In Cash	$61.48M	-1.977M	-1.430M
YoY Change	-4400.34%	-239.88%	-5.19%
FREE CASH FLOW
Cash From Operating Activities	-$16.24M	-$1.866M	-$15.63M
Capital Expenditures	$14.85K	-$29.93K	$155.5K
Free Cash Flow	-$16.25M	-$1.836M	-$15.79M
YoY Change	2.94%	-44.45%	34.09%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value
CY2020	dei	Amendment Flag AmendmentFlag	false
CY2020	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2020	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2020	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2020
CY2020	dei	Document Period End Date DocumentPeriodEndDate	2020-12-31
CY2020	dei	Document Type DocumentType	10-K
CY2020	dei	Entity Central Index Key EntityCentralIndexKey	0001684144
CY2021Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	947298207
CY2020	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2020	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
CY2020	dei	Entity Ex Transition Period EntityExTransitionPeriod	true
CY2020	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2020	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2020Q2	dei	Entity Public Float EntityPublicFloat	82400000
CY2020	dei	Entity Registrant Name EntityRegistrantName	Zomedica Corp.
CY2020	dei	Entity Shell Company EntityShellCompany	false
CY2020	dei	Entity Small Business EntitySmallBusiness	true
CY2020	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2020	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2020Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	146207
CY2019Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	67618
CY2018Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	270405
CY2020	dei	Security12b Title Security12bTitle	Common Shares, without par value
CY2020	dei	Trading Symbol TradingSymbol	zom
CY2020Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	1248628
CY2019Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	2087525
CY2020Q4	us-gaap	Accounts Payable And Accrued Liabilities Current And Noncurrent AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent	1248628
CY2019Q4	us-gaap	Accounts Payable And Accrued Liabilities Current And Noncurrent AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent	2087525
CY2020Q4	us-gaap	Accounts Payable And Accrued Liabilities Noncurrent AccountsPayableAndAccruedLiabilitiesNoncurrent
CY2019Q4	us-gaap	Accounts Payable And Accrued Liabilities Noncurrent AccountsPayableAndAccruedLiabilitiesNoncurrent
CY2019Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	510586
CY2018Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1940265
CY2020Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	61991703
CY2020	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	61481117
CY2019	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-1429679
CY2019Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	546654
CY2020Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	707986
CY2019	us-gaap	Accumulated Depreciation Depletion And Amortization Sale Of Property Plant And Equipment1 AccumulatedDepreciationDepletionAndAmortizationSaleOfPropertyPlantAndEquipment1	901
CY2020	us-gaap	Accumulated Depreciation Depletion And Amortization Sale Of Property Plant And Equipment1 AccumulatedDepreciationDepletionAndAmortizationSaleOfPropertyPlantAndEquipment1	144582
CY2020Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	14792276
CY2019Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	3625083
CY2019	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	2539092
CY2020	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1656184
CY2020	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1656184
CY2019	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	2539092
CY2019	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1082
CY2020	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	181658
CY2020Q4	us-gaap	Assets Assets	66144034
CY2019Q4	us-gaap	Assets Assets	4182984
CY2020Q4	us-gaap	Assets Current AssetsCurrent	62865724
CY2019Q4	us-gaap	Assets Current AssetsCurrent	1806789
CY2020	us-gaap	Basis Of Accounting BasisOfAccounting	<div style="display: inline; font-family: times new roman; font-size: 10pt"><table cellpadding="0" cellspacing="0" style="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; min-width: 700px;"> <tr style="vertical-align: top"> <td style="width: 0.25in"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic; font: inherit;">2.</div></div></td> <td style="text-align: justify"><div style="display: inline; font-weight: bold;">Basis of preparation</div></td> </tr> </table> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0 0pt 0.25in"><div style="display: inline; font-weight: bold;"> </div></div> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0">The accounting policies set out below have been applied consistently in the consolidated financial statements. The consolidated financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America (“U.S. GAAP”).</div> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"><div style="display: inline; font-style: italic;"> </div></div> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"><div style="display: inline; font-style: italic;">Basis of consolidation</div></div> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"><div style="display: inline; font-weight: bold;"> </div></div> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0">These consolidated financial statements include the accounts of the Company and its wholly owned operating subsidiary, Zomedica Pharmaceuticals, Inc.</div> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"> </div> <div style=" font-size: 10pt; margin: 0pt 0">All inter-company accounts and transactions have been eliminated on consolidation.</div></div>
CY2020Q4	us-gaap	Common Stock No Par Value CommonStockNoParValue	0
CY2019Q4	us-gaap	Common Stock No Par Value CommonStockNoParValue	0
CY2020	us-gaap	Common Stock Shares Authorized Unlimited CommonStockSharesAuthorizedUnlimited	Unlimited
CY2019	us-gaap	Common Stock Shares Authorized Unlimited CommonStockSharesAuthorizedUnlimited	Unlimited
CY2020Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	642036228
CY2019Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	108038398
CY2020Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	642036228
CY2019Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	108038398
CY2020Q4	us-gaap	Common Stock Shares Subscriptions CommonStockSharesSubscriptions	459600
CY2019Q4	us-gaap	Common Stock Shares Subscriptions CommonStockSharesSubscriptions
CY2020Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	1148179
CY2019Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	301180
CY2020Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	16625567
CY2019Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	13401070
CY2020Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	94218
CY2019Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	231240
CY2020Q4	us-gaap	Common Stock Value CommonStockValue	104783612
CY2019Q4	us-gaap	Common Stock Value CommonStockValue	38566820
CY2020Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	434460
CY2019Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	231240
CY2020Q4	us-gaap	Deferred Tax Assets Goodwill And Intangible Assets DeferredTaxAssetsGoodwillAndIntangibleAssets	4236169
CY2019Q4	us-gaap	Deferred Tax Assets Goodwill And Intangible Assets DeferredTaxAssetsGoodwillAndIntangibleAssets	3622890
CY2020Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	17060027
CY2019Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	13632310
CY2020Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet
CY2019Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet
CY2020Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	466
CY2019Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	350
CY2020Q4	us-gaap	Deposit Assets DepositAssets	1455119
CY2019Q4	us-gaap	Deposit Assets DepositAssets	1033231
CY2020	us-gaap	Depreciation Depreciation	305914
CY2019	us-gaap	Depreciation Depreciation	277150
CY2019	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	277150
CY2020	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	305914
CY2020	us-gaap	Depreciation Nonproduction DepreciationNonproduction	305914
CY2019	us-gaap	Depreciation Nonproduction DepreciationNonproduction	277150
CY2020	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.05
CY2019	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.19
CY2018Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	8321
CY2019Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	9403
CY2020Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	191061
CY2020Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	184139
CY2020Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	1076
CY2020Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	1076
CY2020Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	1076
CY2020Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	176832
CY2018Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	21379
CY2019Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	552798
CY2020Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	567648
CY2019Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	543395
CY2020Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	376587
CY2019	us-gaap	Finitelived Intangible Assets Acquired1 FinitelivedIntangibleAssetsAcquired1	531419
CY2020	us-gaap	Finitelived Intangible Assets Acquired1 FinitelivedIntangibleAssetsAcquired1	14850
CY2020	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-7403
CY2019	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	182
CY2020Q4	us-gaap	Impaired Assets To Be Disposed Of By Method Other Than Sale Carrying Value Of Asset ImpairedAssetsToBeDisposedOfByMethodOtherThanSaleCarryingValueOfAsset	141434
CY2019Q4	us-gaap	Impaired Assets To Be Disposed Of By Method Other Than Sale Carrying Value Of Asset ImpairedAssetsToBeDisposedOfByMethodOtherThanSaleCarryingValueOfAsset	1308
CY2019	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-19784054
CY2019	us-gaap	Income Tax Reconciliation Change In Enacted Tax Rate IncomeTaxReconciliationChangeInEnactedTaxRate
CY2020	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	-74847
CY2020	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	-121034
CY2019	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	-1308
CY2020	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-121034
CY2019	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-1308
CY2020	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	6011985
CY2019	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	6985334
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-16911784
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit
CY2019	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit
CY2020	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	3224503
CY2019	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	4453160
CY2020	us-gaap	Income Tax Reconciliation Change In Enacted Tax Rate IncomeTaxReconciliationChangeInEnactedTaxRate	1540539
CY2020	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-4058828
CY2019	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-5341690
CY2020	us-gaap	Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost	407689
CY2019	us-gaap	Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost	771640
CY2020	us-gaap	Income Tax Reconciliation Prior Year Income Taxes IncomeTaxReconciliationPriorYearIncomeTaxes	32518
CY2019	us-gaap	Income Tax Reconciliation Prior Year Income Taxes IncomeTaxReconciliationPriorYearIncomeTaxes
CY2019	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	54660
CY2020	us-gaap	Increase Decrease In Accounts And Other Receivables IncreaseDecreaseInAccountsAndOtherReceivables	78589
CY2019	us-gaap	Increase Decrease In Accounts And Other Receivables IncreaseDecreaseInAccountsAndOtherReceivables	13959
CY2020	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-838897
CY2019	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-288994
CY2020	us-gaap	Increase Decrease In Deposit Other Assets IncreaseDecreaseInDepositOtherAssets	721156
CY2019	us-gaap	Increase Decrease In Deposit Other Assets IncreaseDecreaseInDepositOtherAssets	-92873
CY2020	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	77341
CY2019	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-239953
CY2020	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants
CY2019	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants
CY2020	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
CY2019	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
CY2020Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	376587
CY2019Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	543395
CY2020	us-gaap	Interest Expense InterestExpense	732
CY2019	us-gaap	Interest Expense InterestExpense	18338
CY2020	us-gaap	Interest Income Operating InterestIncomeOperating	32859
CY2019	us-gaap	Interest Income Operating InterestIncomeOperating
CY2020	us-gaap	Interest Paid Net InterestPaidNet	732
CY2019	us-gaap	Interest Paid Net InterestPaidNet	18338
CY2020	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims
CY2019	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	792104
CY2020Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	1710533
CY2020Q4	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	400133
CY2020Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	36526
CY2020Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	437236
CY2020Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	424501
CY2020Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	412137
CY2020Q4	us-gaap	Liabilities Liabilities	3116774
CY2019Q4	us-gaap	Liabilities Liabilities	2087525
CY2020Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	66144034
CY2019Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	4182984
CY2020Q4	us-gaap	Liabilities Current LiabilitiesCurrent	2028776
CY2019Q4	us-gaap	Liabilities Current LiabilitiesCurrent	2087525
CY2020Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	1087998
CY2019Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent
CY2020Q4	us-gaap	Long Term Debt LongTermDebt	527360
CY2019Q4	us-gaap	Long Term Debt LongTermDebt
CY2020Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	527360
CY2019Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent
CY2020Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent
CY2019Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent
CY2020	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	76714761
CY2019	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	14891317
CY2020	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	1005719
CY2019	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-686932
CY2020	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-16239363
CY2019	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-15634064
CY2019	us-gaap	Net Income Loss NetIncomeLoss	-19784054
CY2020	us-gaap	Net Income Loss NetIncomeLoss	-16911784
CY2020	us-gaap	Operating Income Loss OperatingIncomeLoss	-16764978
CY2019	us-gaap	Operating Income Loss OperatingIncomeLoss	-19784327
CY2020	us-gaap	Operating Lease Impairment Loss OperatingLeaseImpairmentLoss	59097
CY2019	us-gaap	Operating Lease Impairment Loss OperatingLeaseImpairmentLoss
CY2020Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	1340786
CY2019Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability
CY2020Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	252788
CY2019Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent
CY2020Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1087998
CY2019Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent
CY2020	us-gaap	Operating Lease Payments OperatingLeasePayments	356972
CY2020Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1318716
CY2019Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1103658
CY2020	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	42448
CY2019	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	509381
CY2020	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	0
CY2019	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	0
CY2020	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	8601
CY2019	us-gaap	Other Nonoperating Income OtherNonoperatingIncome
CY2020Q4	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	62211
CY2019Q4	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	64889
CY2020	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	5107616
CY2019	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	708683
CY2020	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	1944
CY2019	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	531419
CY2020	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	14850
CY2019	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	155513
CY2020Q4	us-gaap	Preferred Stock No Par Value PreferredStockNoParValue	0
CY2019Q4	us-gaap	Preferred Stock No Par Value PreferredStockNoParValue	0
CY2020Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	20
CY2019Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	20
CY2020Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	12
CY2019Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	12
CY2020Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-68969625
CY2020	us-gaap	Reclassifications Reclassifications	<div style="display: inline; font-family: times new roman; font-size: 10pt"><table cellpadding="0" cellspacing="0" style="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; min-width: 700px;"> <tr style="vertical-align: top"> <td style="width: 0"></td> <td style="width: 0.25in"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic; font: inherit;">22.</div></div></td> <td style="text-align: justify"><div style="display: inline; font-weight: bold;">Comparative figures</div></td> </tr> </table> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0 0pt 0.25in"><div style="display: inline; font-weight: bold;"> </div></div> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0">Certain prior year amounts have been reclassified for consistency with the current year presentation. These reclassifications had <div style="display: inline; font-style: italic; font: inherit;">no</div> effect on the reported results of operations. Adjustments have been made to the consolidated schedule of expenses for the year ended <div style="display: inline; font-style: italic; font: inherit;"> December 31, 2019 </div>to classify health insurance benefits as part of salaries, wages and bonuses, and audit fees to professional fees. This change in classification does <div style="display: inline; font-style: italic; font: inherit;">not</div> affect previously reported cash flows from operating activities in the consolidated statements of cash flows.</div></div>
CY2020Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	12
CY2019Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	12
CY2020Q4	us-gaap	Preferred Stock Value PreferredStockValue
CY2019Q4	us-gaap	Preferred Stock Value PreferredStockValue	11961397
CY2020Q4	us-gaap	Prepaid Advertising PrepaidAdvertising	26330
CY2019Q4	us-gaap	Prepaid Advertising PrepaidAdvertising	19829
CY2020Q4	us-gaap	Prepaid Insurance PrepaidInsurance	184154
CY2019Q4	us-gaap	Prepaid Insurance PrepaidInsurance	110636
CY2020	us-gaap	Proceeds From Interest And Dividends Received ProceedsFromInterestAndDividendsReceived	32353
CY2019	us-gaap	Proceeds From Interest And Dividends Received ProceedsFromInterestAndDividendsReceived
CY2020	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	56496283
CY2019	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	3000000
CY2020	us-gaap	Proceeds From Issuance Of Preferred Stock And Preference Stock ProceedsFromIssuanceOfPreferredStockAndPreferenceStock
CY2019	us-gaap	Proceeds From Issuance Of Preferred Stock And Preference Stock ProceedsFromIssuanceOfPreferredStockAndPreferenceStock	12000000
CY2020	us-gaap	Proceeds From Sales Of Assets Investing Activities ProceedsFromSalesOfAssetsInvestingActivities	20400
CY2019	us-gaap	Proceeds From Sales Of Assets Investing Activities ProceedsFromSalesOfAssetsInvestingActivities	0
CY2020	us-gaap	Proceeds From Short Term Debt ProceedsFromShortTermDebt	527360
CY2019	us-gaap	Proceeds From Short Term Debt ProceedsFromShortTermDebt
CY2019	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	600000
CY2020	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	24339134
CY2019	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	600000
CY2020	us-gaap	Professional Fees ProfessionalFees	2179082
CY2019	us-gaap	Professional Fees ProfessionalFees	1666089
CY2019	us-gaap	Property Plant And Equipment Additions PropertyPlantAndEquipmentAdditions	290513
CY2020	us-gaap	Property Plant And Equipment Additions PropertyPlantAndEquipmentAdditions	301212
CY2019	us-gaap	Property Plant And Equipment Disposals PropertyPlantAndEquipmentDisposals	2210
CY2020	us-gaap	Property Plant And Equipment Disposals PropertyPlantAndEquipmentDisposals	286016
CY2018Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	987493
CY2019Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	1275796
CY2020Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	1290993
CY2019Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	729142
CY2020Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	583007
CY2020	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	8043891
CY2020	us-gaap	Related Party Transaction Amounts Of Transaction RelatedPartyTransactionAmountsOfTransaction	0
CY2019Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-52057841
CY2019	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	10345291
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0051
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0034
CY2019Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0256
CY2020Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0049
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0027
CY2020Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0024
CY2020Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.003
CY2019Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	5000
CY2019Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	5000
CY2019Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0148
CY2019Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0174
CY2019Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	35000
CY2019Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	10000
CY2019Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	40000
CY2019Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	387004
CY2020	us-gaap	Share Based Compensation ShareBasedCompensation	1656184
CY2019	us-gaap	Share Based Compensation ShareBasedCompensation	2539092
CY2020Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice	0.18
CY2020Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice	0.19
CY2020Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice	0.19
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice	0.11
CY2020Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice	0.11
CY2020Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice	0.13
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice	0.23
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice	0.09
CY2019Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice	1.52
CY2019Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice
CY2019Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice	0.43
CY2020Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0
CY2020Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0
CY2020Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0
CY2020Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0
CY2020Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0
CY2019Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0
CY2019Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0
CY2019Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0
CY2020Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	1
CY2020Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	1
CY2020Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.87
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	1
CY2020Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	1
CY2020Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.99
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	1.02
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	1
CY2019Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.68
CY2019Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.87
CY2019Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.89
CY2020Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0028
CY2020Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0021
CY2020Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	50000
CY2020Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	5000
CY2020Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	50000
CY2019	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	7495000
CY2019Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	5995000
CY2019Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	500000
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber	14624140
CY2020Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	150000
CY2019Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	15000
CY2020Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	30000
CY2020Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	15000
CY2020Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	15000
CY2020Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	400000
CY2020Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	3750
CY2020Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	10000
CY2020Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	675000
CY2020Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	75375
CY2020Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	37500
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	56250
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	1250
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	225000
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	25125
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	12500
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	35471000
CY2019Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	500000
CY2020Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	5056000
CY2020Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	2000000
CY2020Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	175000
CY2020Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	40000
CY2020Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	300000
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	300000
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	40000
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	27560000
CY2018Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	422044
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	7040265
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	39604515
CY2018Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	1.95
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	1.28
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.36
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice	0.59
CY2019Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	1.52
CY2019Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	1.52
CY2019Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	1.52
CY2019Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice	1.15
CY2019Q2	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice	1.52
CY2019Q2	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice	1.52
CY2019Q3	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice	2.11
CY2019Q3	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	1.52
CY2019Q3	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	1.52
CY2020Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	1.52
CY2020Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	1.12
CY2020Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	1.52
CY2020Q2	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	0.19
CY2019Q2	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	0.19
CY2020Q2	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	1.52
CY2020Q2	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	1.52
CY2020Q2	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	1.52
CY2020Q3	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	1.52
CY2020Q3	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	0.19
CY2020Q3	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	1.52
CY2020Q3	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	0.19
CY2020Q3	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	0.19
CY2020Q3	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	0.19
CY2020Q4	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	0.19
CY2020Q4	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	0.19
CY2020Q4	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	0.19
CY2020Q4	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	0.19
CY2020Q4	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	0.19
CY2019Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	1.52
CY2019Q3	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0.26
CY2019Q3	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0.43
CY2020Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0.19
CY2020Q2	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0.19
CY2020Q3	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0.18
CY2020Q3	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0.13
CY2020Q3	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0.11
CY2020Q4	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0.11
CY2020Q4	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0.09
CY2020Q4	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0.23
CY2020	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0.23
CY2020Q3	us-gaap	Share Price SharePrice	0.17
CY2020Q2	us-gaap	Share Price SharePrice	0.19
CY2020Q1	us-gaap	Share Price SharePrice	0.18
CY2020Q4	us-gaap	Share Price SharePrice	0.10
CY2020Q3	us-gaap	Share Price SharePrice	0.10
CY2020Q3	us-gaap	Share Price SharePrice	0.13
CY2020Q4	us-gaap	Share Price SharePrice	0.23
CY2020Q4	us-gaap	Share Price SharePrice	0.08
CY2019Q1	us-gaap	Share Price SharePrice	1.23
CY2019Q3	us-gaap	Share Price SharePrice	0.26
CY2019Q3	us-gaap	Share Price SharePrice	0.42
CY2020Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P5Y
CY2020Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P5Y
CY2020Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P5Y
CY2020Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P5Y
CY2020Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P5Y
CY2020Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P5Y
CY2020Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P5Y273D
CY2020Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P5Y
CY2019Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P2Y
CY2019Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P2Y
CY2019Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P2Y
CY2020Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares	24980375
CY2019	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares	7040265
CY2020	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares	14624140
CY2020	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	0
CY2019	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	394735
CY2019Q1	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	164473
CY2019Q1	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	164473
CY2019Q1	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	65789
CY2019	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	792104
CY2020	zom	Gain Loss On Settlement Of Liabilities GainLossOnSettlementOfLiabilities
CY2019	zom	Gain Loss On Settlement Of Liabilities GainLossOnSettlementOfLiabilities	19737
CY2020Q1	zom	Issuance Of Common Shares And Warrants Direct Costs Of Issuance IssuanceOfCommonSharesAndWarrantsDirectCostsOfIssuance	348220
CY2020Q2	zom	Issuance Of Common Shares And Warrants Direct Costs Of Issuance IssuanceOfCommonSharesAndWarrantsDirectCostsOfIssuance	582977
CY2020Q2	zom	Issuance Of Common Shares And Warrants Direct Costs Of Issuance IssuanceOfCommonSharesAndWarrantsDirectCostsOfIssuance	1908202
CY2020Q3	zom	Issuance Of Common Shares And Warrants Direct Costs Of Issuance IssuanceOfCommonSharesAndWarrantsDirectCostsOfIssuance	2268215
CY2020	zom	Issuance Of Common Shares And Warrants Direct Costs Of Issuance IssuanceOfCommonSharesAndWarrantsDirectCostsOfIssuance	5107616
CY2020Q4	zom	Operating Lease Right Of Use Asset Aggregate Lease Commitments OperatingLeaseRightOfUseAssetAggregateLeaseCommitments	2067505
CY2020	zom	Operating Lease Right Of Use Asset Amortization OperatingLeaseRightOfUseAssetAmortization	379043
CY2020	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	56496283
CY2019	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	600000
CY2018Q4	us-gaap	Stockholders Equity StockholdersEquity	3657000
CY2019Q4	us-gaap	Stockholders Equity StockholdersEquity	2095459
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	51065863
CY2020	us-gaap	Use Of Estimates UseOfEstimates	<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"><div style="display: inline; font-style: italic;">Use of estimates</div></div> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"> </div> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0">The preparation of the consolidated financial statements in conformity with U.S GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenue and expenses during the period. Actual results could differ from those estimates.</div></div></div></div></div></div></div>
CY2020	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	364444664
CY2019	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	106297975
CY2020	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	364444664
CY2019	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	106297975
CY2020	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	364444664
CY2019	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	106297975
CY2020Q4	zom	Accounts Payable And Accrued Liabilities Due In3 To6 Months AccountsPayableAndAccruedLiabilitiesDueIn3To6Months
CY2019Q4	zom	Accounts Payable And Accrued Liabilities Due In3 To6 Months AccountsPayableAndAccruedLiabilitiesDueIn3To6Months
CY2020Q4	zom	Accounts Payable And Accrued Liabilities Due In6 To9 Months AccountsPayableAndAccruedLiabilitiesDueIn6To9Months
CY2019Q4	zom	Accounts Payable And Accrued Liabilities Due In6 To9 Months AccountsPayableAndAccruedLiabilitiesDueIn6To9Months
CY2020Q4	zom	Accounts Payable And Accrued Liabilities Due In9 To12 Months AccountsPayableAndAccruedLiabilitiesDueIn9To12Months
CY2019Q4	zom	Accounts Payable And Accrued Liabilities Due In9 To12 Months AccountsPayableAndAccruedLiabilitiesDueIn9To12Months
CY2020Q4	zom	Accounts Payable And Accrued Liabilities Due Less Than3 Months AccountsPayableAndAccruedLiabilitiesDueLessThan3Months	1248628
CY2019Q4	zom	Accounts Payable And Accrued Liabilities Due Less Than3 Months AccountsPayableAndAccruedLiabilitiesDueLessThan3Months	2087525
CY2020	zom	Adjustments To Equity Warrant Issued AdjustmentsToEquityWarrantIssued
CY2020	zom	Class Of Warrant Or Right Issued During Period ClassOfWarrantOrRightIssuedDuringPeriod	202020823
CY2020	zom	Common Stock Subscribed CommonStockSubscribed	459600
CY2020Q4	zom	Deferred Tax Assets Non Capital Losses Carryforwards DeferredTaxAssetsNonCapitalLossesCarryforwards	6182002
CY2019Q4	zom	Deferred Tax Assets Non Capital Losses Carryforwards DeferredTaxAssetsNonCapitalLossesCarryforwards	5498910
CY2020Q4	zom	Deferred Tax Assets Operating Leases DeferredTaxAssetsOperatingLeases	345937
CY2019Q4	zom	Deferred Tax Assets Operating Leases DeferredTaxAssetsOperatingLeases	6560
CY2020Q4	zom	Deferred Tax Assets Schedule13 Reserves DeferredTaxAssetsSchedule13Reserves	28784
CY2019Q4	zom	Deferred Tax Assets Schedule13 Reserves DeferredTaxAssetsSchedule13Reserves	20410
CY2020Q4	zom	Deferred Tax Liabilities Right Of Use Asset DeferredTaxLiabilitiesRightOfUseAsset	340242
CY2019Q4	zom	Deferred Tax Liabilities Right Of Use Asset DeferredTaxLiabilitiesRightOfUseAsset
CY2020	zom	Effective Income Tax Rate Reconciliation Combined Federal And Provincial Statutory Income Tax Rate Percent EffectiveIncomeTaxRateReconciliationCombinedFederalAndProvincialStatutoryIncomeTaxRatePercent	0.27
CY2019	zom	Effective Income Tax Rate Reconciliation Combined Federal And Provincial Statutory Income Tax Rate Percent EffectiveIncomeTaxRateReconciliationCombinedFederalAndProvincialStatutoryIncomeTaxRatePercent	0.27
CY2020	zom	Effective Income Tax Rate Reconciliation Foreign Accrual Property Income EffectiveIncomeTaxRateReconciliationForeignAccrualPropertyIncome	210605
CY2019	zom	Effective Income Tax Rate Reconciliation Foreign Accrual Property Income EffectiveIncomeTaxRateReconciliationForeignAccrualPropertyIncome	261160
CY2020	zom	Effective Income Tax Rate Reconciliation Share Issuance Costs Recorded In Equity EffectiveIncomeTaxRateReconciliationShareIssuanceCostsRecordedInEquity	-1282179
CY2019	zom	Effective Income Tax Rate Reconciliation Share Issuance Costs Recorded In Equity EffectiveIncomeTaxRateReconciliationShareIssuanceCostsRecordedInEquity	-198930
CY2020Q4	zom	Finitelived Intangible Assets Expected Amortization Year One To Five FinitelivedIntangibleAssetsExpectedAmortizationYearOneToFive	364199
CY2020Q4	zom	Liabilities Due In3 To6 Months LiabilitiesDueIn3To6Months	62463
CY2019Q4	zom	Liabilities Due In3 To6 Months LiabilitiesDueIn3To6Months
CY2020Q4	zom	Liabilities Due In6 To9 Months LiabilitiesDueIn6To9Months	64356
CY2019Q4	zom	Liabilities Due In6 To9 Months LiabilitiesDueIn6To9Months
CY2020Q4	zom	Liabilities Due In9 To12 Months LiabilitiesDueIn9To12Months	66307
CY2019Q4	zom	Liabilities Due In9 To12 Months LiabilitiesDueIn9To12Months
CY2020Q4	zom	Liabilities Due In Less Than3 Months LiabilitiesDueInLessThan3Months	1835650
CY2019Q4	zom	Liabilities Due In Less Than3 Months LiabilitiesDueInLessThan3Months	2087525
CY2020Q4	zom	Longterm Debt Due In3 To6 Months LongtermDebtDueIn3To6Months
CY2019Q4	zom	Longterm Debt Due In3 To6 Months LongtermDebtDueIn3To6Months
CY2020Q4	zom	Longterm Debt Due In6 To9 Months LongtermDebtDueIn6To9Months
CY2019Q4	zom	Longterm Debt Due In6 To9 Months LongtermDebtDueIn6To9Months
CY2020Q4	zom	Longterm Debt Due In9 To12 Months LongtermDebtDueIn9To12Months
CY2019Q4	zom	Longterm Debt Due In9 To12 Months LongtermDebtDueIn9To12Months
CY2020Q4	zom	Longterm Debt Due Less Than3 Months LongtermDebtDueLessThan3Months	527360
CY2019Q4	zom	Longterm Debt Due Less Than3 Months LongtermDebtDueLessThan3Months
CY2020	zom	Noncash Rent Expense NoncashRentExpense	22069
CY2019	zom	Noncash Rent Expense NoncashRentExpense
CY2019Q4	zom	Number Of Lease Agreements NumberOfLeaseAgreements	2
CY2020	zom	Operating Lease Liability Additions OperatingLeaseLiabilityAdditions	1553611
CY2020Q4	zom	Operating Lease Liability Due In3 To6 Months OperatingLeaseLiabilityDueIn3To6Months	62463
CY2019Q4	zom	Operating Lease Liability Due In3 To6 Months OperatingLeaseLiabilityDueIn3To6Months
CY2020Q4	zom	Operating Lease Liability Due In6 To9 Months OperatingLeaseLiabilityDueIn6To9Months	64356
CY2019Q4	zom	Operating Lease Liability Due In6 To9 Months OperatingLeaseLiabilityDueIn6To9Months
CY2020Q4	zom	Operating Lease Liability Due In9 To12 Months OperatingLeaseLiabilityDueIn9To12Months	66307
CY2019Q4	zom	Operating Lease Liability Due In9 To12 Months OperatingLeaseLiabilityDueIn9To12Months
CY2020Q4	zom	Operating Lease Liability Due Less Than3 Months OperatingLeaseLiabilityDueLessThan3Months	59662
CY2019Q4	zom	Operating Lease Liability Due Less Than3 Months OperatingLeaseLiabilityDueLessThan3Months
CY2020	zom	Operating Lease Liability Interest OperatingLeaseLiabilityInterest	144147
CY2020Q4	zom	Operating Lease Right Of Use Asset Accumulated Amortization OperatingLeaseRightOfUseAssetAccumulatedAmortization	234895
CY2020Q4	zom	Operating Lease Right Of Use Asset Cost OperatingLeaseRightOfUseAssetCost	1553611
CY2020Q4	zom	Operating Lease Right Of Use Asset Impact Of Present Value OperatingLeaseRightOfUseAssetImpactOfPresentValue	513894
CY2020	zom	Operating Lease Rightofuse Asset Interest OperatingLeaseRightofuseAssetInterest	-144148
CY2020Q4	zom	Prepaid Expenses And Deposits PrepaidExpensesAndDeposits	1727814
CY2019Q4	zom	Prepaid Expenses And Deposits PrepaidExpensesAndDeposits	1228585
CY2020Q4	zom	Prepaid Expenses And Deposits Current PrepaidExpensesAndDepositsCurrent	727814
CY2019Q4	zom	Prepaid Expenses And Deposits Current PrepaidExpensesAndDepositsCurrent	1228585
CY2020Q4	zom	Prepaid Expenses And Deposits Noncurrent PrepaidExpensesAndDepositsNoncurrent	1000000
CY2019Q4	zom	Prepaid Expenses And Deposits Noncurrent PrepaidExpensesAndDepositsNoncurrent	0
CY2020	zom	Proceeds From Common Stock Subscribed ProceedsFromCommonStockSubscribed	459600
CY2019	zom	Proceeds From Common Stock Subscribed ProceedsFromCommonStockSubscribed
CY2020	zom	Proceeds From Refund Of Prepaid Rent ProceedsFromRefundOfPrepaidRent	1002113
CY2019	zom	Proceeds From Refund Of Prepaid Rent ProceedsFromRefundOfPrepaidRent
CY2020Q4	zom	Property Plant And Equipment Including Leased Assets PropertyPlantAndEquipmentIncludingLeasedAssets	1901723
CY2019Q4	zom	Property Plant And Equipment Including Leased Assets PropertyPlantAndEquipmentIncludingLeasedAssets	1832800
CY2020	zom	Reclassification To Temporary Equity Amount ReclassificationToTemporaryEquityAmount	11961397
CY2020Q2	zom	Stock Issued During Period Shares Exercise Of Warrants And Prefunded Warrants StockIssuedDuringPeriodSharesExerciseOfWarrantsAndPrefundedWarrants	12162492
CY2020Q3	zom	Stock Issued During Period Shares Exercise Of Warrants And Prefunded Warrants StockIssuedDuringPeriodSharesExerciseOfWarrantsAndPrefundedWarrants	24984492
CY2020	zom	Stock Issued During Period Value Exercise Of Warrants And Prefunded Warrants StockIssuedDuringPeriodValueExerciseOfWarrantsAndPrefundedWarrants	24339134
CY2019	zom	Stock Issued During Period Value Issued For Financing Net Of Cost StockIssuedDuringPeriodValueIssuedForFinancingNetOfCost	14291317

Files In Submission

Name	View Source	Status
0001171843-21-001378-index-headers.html	Edgar Link	pending
0001171843-21-001378-index.html	Edgar Link	pending
0001171843-21-001378.txt	Edgar Link	pending
0001171843-21-001378-xbrl.zip	Edgar Link	pending
exh_1011.htm	Edgar Link	pending
exh_211.htm	Edgar Link	pending
exh_231.htm	Edgar Link	pending
exh_311.htm	Edgar Link	pending
exh_312.htm	Edgar Link	pending
exh_321.htm	Edgar Link	pending
f10k_022621p.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
mnp_logo.jpg	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
zom-20201231.xml	Edgar Link	completed
zom-20201231.xsd	Edgar Link	pending
zom-20201231_cal.xml	Edgar Link	unprocessable
zom-20201231_def.xml	Edgar Link	unprocessable
zom-20201231_lab.xml	Edgar Link	unprocessable
zom-20201231_pre.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$ZOM
Zomedica Corp. Stock $zom

2020 Form 10-K Financial Statement

#000117184321001378 Filed on February 26, 2021

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ZOM Zomedica Corp. Stock $zom

2020 Form 10-K Financial Statement

#000117184321001378 Filed on February 26, 2021

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ZOM
Zomedica Corp. Stock $zom